B-Vitamin Coenzyme Roles and Deficiency Impact
B vitamins function as coenzymes or coenzyme precursors in essential metabolic pathways: B1 (thiamine; TPP) in pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, transketolase; B2 (riboflavin; FAD/FMN) in Complex I, Complex II, fatty acid oxidation, glutathione reductase; B3 (niacin; NAD+/NADH, NADP+/NADPH) in >400 redox reactions; B5 (pantothenic acid; CoA) in acyl carrier function; B6 (P5P) in 100+ aminotransferase/decarboxylase reactions (neurotransmitter synthesis, haemoglobin, serine/glycine metabolism); folate (5-MTHF) in one-carbon transfer (thymidylate, purine synthesis, methylation); B12 (methylcobalamin) in methionine synthase and methylmalonyl-CoA mutase. Sub-clinical deficiencies are common: 15–25% of populations show sub-optimal B2/B6 status; folate deficiency affects 10–20%; B12 deficiency affects 6% of under-60s and >20% of over-60s.
Spirulina B-Vitamin Mechanisms
Thiamine (B1) and Carbohydrate Energy Metabolism
Spirulina thiamine (~2.4 mg/100g; 0.24 mg per 10g — 20% RDI) as thiamine pyrophosphate (TPP) activates three critical dehydrogenases: pyruvate dehydrogenase (glucose→acetyl-CoA; PDH complex requires TPP, FAD, NAD+, lipoate, CoA); α-ketoglutarate dehydrogenase (TCA cycle; ATP generation step); and transketolase (pentose phosphate pathway; NADPH generation). TPP deficiency impairs carbohydrate oxidation, causing lactate accumulation (PDH failure), reduced TCA flux, and NADPH deficiency (reduced antioxidant capacity via glutathione reductase). Spirulina B1 provision particularly benefits neurological function (brain is 100% glucose-dependent for energy), relevant to thiamine-marginal populations (alcohol use, poor diet, GI malabsorption).
Riboflavin (B2) and FAD/FMN-Dependent Pathways
Riboflavin (~3.7 mg/100g; 0.37 mg per 10g — 28% RDI) as FAD supports: Complex I (NADH→FAD reduction in electron transport), Complex II (FADH2 in succinate dehydrogenase), Complex III (ETFDH in fatty acid β-oxidation electron feeding), glutathione reductase (maintaining GSH/GSSG ratio via FADH2-driven NADP+ reduction), MTHFR (5,10-methyleneTHF reductase; FAD cofactor for folate cycle), and D-amino acid oxidase (FAD enzyme). B2 deficiency impairs all these pathways simultaneously, with mitochondrial and antioxidant consequences. Spirulina B2 is clinically important for women of reproductive age (pregnancy increases B2 demand 20%), athletes (elevated B2 turnover), and the elderly.
Niacin (B3), NAD+ Biosynthesis, and SIRT1/PARP Signalling
Spirulina niacin (~11.8 mg/100g; ~1.2 mg per 10g — 8% RDI) as NAD+ precursor supports: Complex I (NADH electron donor; largest contributor to mitochondrial ATP yield); SIRT1/SIRT3 deacetylases (NAD+ substrate; histone deacetylation for longevity gene expression); PARP1 (poly-ADP-ribose polymerase; DNA repair enzyme consuming NAD+); and CD38 (NADase; regulates NAD+ availability). In ageing, NAD+ levels decline 50–80% due to increased CD38 activity and decreased NAMPT-mediated biosynthesis. Spirulina AMPK activation increases NAMPT expression (rate-limiting NAD+ biosynthesis enzyme), amplifying the niacin provision into higher NAD+ availability and SIRT1 activity (+20–25% SIRT1 activity in ageing models).
B6 (P5P), Folate, and Methyl Cycle Support
B6 as pyridoxal-5-phosphate (P5P; ~0.8–1.2 mg/100g spirulina) activates >100 enzyme reactions: dopa decarboxylase (L-DOPA→dopamine); AADC (5-HTP→serotonin); ALAS (δ-aminolevulinic acid synthase; haem synthesis); CBS (cystathionine β-synthase; homocysteine→cystathionine; deficiency causes hyperhomocysteinaemia); PSAT1 (serine synthesis); and kynurenine aminotransferase (kynurenine→kynurenic acid). Folate (~0.6–1.2 mg/100g; largely as 5-methyltetrahydrofolate derivatives) provides one-carbon units for: thymidylate synthase (dUMP→dTMP, DNA synthesis); methionine synthase (homocysteine→methionine, with B12); and MTHFR (5-MTHF generation). Combined B6+folate provision reduces homocysteine (−2–5 μmol/L), lowering cardiovascular risk.
Clinical Outcomes from B-Vitamin Provision
- Serum homocysteine: −2–5 μmol/L
- RBC folate: +15–25% at 12 weeks
- Erythrocyte glutathione reductase (B2 status): Normalised in deficiency
- Plasma NAD+ (niacin metabolite NMN): +15–25%
- Serotonin/dopamine precursor availability (B6 effect): +10–20% urinary 5-HIAA
- Neurological function score (B-vitamin composite): +8–15% in sub-optimal status
Dosing and Drug Interactions
B-vitamin support: 5–10g daily; provides significant but partial B-vitamin requirements. Metformin: Reduces B12 absorption (ileal B12/IF receptor impairment); spirulina B12 is largely inactive analogues — confirm active methylcobalamin/adenosylcobalamin content. Isoniazid/hydralazine: Increase B6 requirements; spirulina B6 provision is supportive. MTX (methotrexate): Folate antagonist; spirulina folate is insufficient to overcome MTX block — dedicated folinic acid required. Summary: B1 20% RDI, B2 28% RDI, B3 8% RDI + NAMPT upregulation, B6 P5P activation, folate 5-MTHF, homocysteine −2–5 μmol/L; dosing 5–10g daily. NK concern: low.